MTM Documentation & Clinical Communication 3 — Questions and Answers
Question 1: A pharmacist discovers during documentation review that a patient's EHR contains a medication allergy that was never communicated to the current prescriber. The BEST action is to:
- Update the allergy field and assume the prescriber will notice
- Contact the prescriber directly to communicate the allergy and document the notification (Correct answer)
- Wait until the patient's next CMR to address the discrepancy
- Remove the allergy entry if the patient denies ever having a reaction
Correct answer: Contact the prescriber directly to communicate the allergy and document the notification
Direct communication to the prescriber followed by documentation of that notification closes the loop and ensures patient safety in an active care scenario.
Question 2: Which element differentiates a CMR follow-up document from an initial CMR summary in MTM documentation standards?
- The follow-up omits the Medication Action Plan
- The follow-up focuses on progress toward goals identified in the prior CMR (Correct answer)
- The follow-up requires a new Personal Medication Record from scratch
- The follow-up does not require patient signature
Correct answer: The follow-up focuses on progress toward goals identified in the prior CMR
Follow-up CMR documentation centers on evaluating progress toward previously identified goals and updating the action plan based on outcomes.
Question 3: When documenting a drug interaction identified during MTM, the pharmacist should specify the interaction's:
- Trade name only, to match pharmacy dispensing records
- Severity, clinical significance, and recommended management strategy (Correct answer)
- Cost comparison between the interacting agents
- Number of times the interaction has occurred in the patient's history
Correct answer: Severity, clinical significance, and recommended management strategy
Complete drug interaction documentation requires severity classification, clinical significance, and the recommended action or monitoring plan to guide care decisions.
Question 4: A patient declines a pharmacist's recommendation to change their medication during an MTM session. How should this be documented?
- Omit the recommendation to avoid legal liability
- Document the recommendation made, the patient's refusal, and any education provided (Correct answer)
- Document only that the session was completed without changes
- Flag the patient as non-compliant in the chart without further detail
Correct answer: Document the recommendation made, the patient's refusal, and any education provided
Documentation must reflect the recommendation offered, patient's informed refusal, and education provided to support continuity of care and legal protection.
Question 5: In the context of MTM documentation, 'medication reconciliation' is BEST described as:
- Comparing a patient's medication orders across care transitions to identify discrepancies (Correct answer)
- Verifying that medication costs match the patient's insurance plan formulary
- Confirming that all medications are filled at the same pharmacy
- Reconciling the pharmacist's billing codes with insurance reimbursement rates
Correct answer: Comparing a patient's medication orders across care transitions to identify discrepancies
Medication reconciliation involves comparing medication lists across care transitions (e.g., hospital to home) to identify and resolve discrepancies that could cause harm.
Question 6: Which of the following BEST describes the purpose of documenting clinical endpoints (e.g., HbA1c, blood pressure) in an MTM note?
- To satisfy CMS billing requirements only
- To provide objective evidence of therapeutic outcomes and guide future interventions (Correct answer)
- To replace the need for physician laboratory orders
- To document pharmacist prescribing authority
Correct answer: To provide objective evidence of therapeutic outcomes and guide future interventions
Recording clinical endpoints provides objective, measurable data to assess therapeutic progress and adjust medication management plans accordingly.
Question 7: A pharmacist is documenting a CMR completed via telehealth. Which additional element should be included in the documentation compared to an in-person encounter?
- Duplicate paper records mailed to the patient
- The telehealth platform used and confirmation that the patient consented to the virtual visit (Correct answer)
- A higher billing code to account for technology overhead
- A note that physical examination was performed remotely
Correct answer: The telehealth platform used and confirmation that the patient consented to the virtual visit
Telehealth documentation must include the modality used and evidence of patient consent to the virtual format to meet regulatory and payer requirements.
MTM Documentation & Clinical Communication 3
A pharmacist discovers during documentation review that a patient's EHR contains a medication allergy that was never communicated to the current prescriber.
The BEST action is to: